ASCO, the largest event in cancer research, is approaching on May 31st. This year's meeting promises to be particularly groundbreaking, with new findings and innovations that could revolutionize cancer treatment.
Indica Labs, an industry leader in AI-powered digital pathology solutions, and Hamamatsu Photonics K.K., a pioneer in whole slide imaging systems, announce that the U.S. Food and Drug Administration (FDA) has issued a 510(k) clearance to Indica Labs for HALO AP Dx, an enterprise digital pathology platform. HALO AP Dx is indicated for primary diagnosis of surgical pathology slides prepared from formalin-fixed paraffin embedded (FFPE) tissue scanned by the NanoZoomer® S360MD Slide scanner1.
Researchers at Sinai Hospital of Baltimore have found a possible relationship between receiving chemotherapy within a year of total joint replacement surgery and increased incidence of infection in the replaced joint. Findings published this month in the Archives of Orthopaedic and Trauma Surgery.
If you and your infant are struggling with breastfeeding, it’s natural to feel concerned. A tongue-tie is one possible cause of these difficulties. A tongue-tie (ankyloglossia) may affect your baby’s ability to feed efficiently. To treat this condition, doctors may discuss a tongue-tie release procedure with you, which can help the tongue move more functionally. Other treatments options include feeding therapy and working with a lactation consultant.
Up to 18% of patients undergoing ACL reconstruction experience graft failure and require revision surgery, which is known to increase the risk of developing post-traumatic osteoarthritis (PTOA).
Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC), according to researchers from The University of Texas MD Anderson Cancer Center.
Hackensack Meridian Jersey Shore University Medical Center celebrates a significant milestone: the attainment of Global Healthcare Accreditation (GHA) for Medical Travel Services for its Center for Treatment of Paralysis and Reconstructive Nerve Surgery. The Center is the first GHA accredited facility in New Jersey.
Cedars-Sinai experts in pulmonology, critical care medicine and lung transplant attending the May 17-22 American Thoracic Society’s (ATS) 2024 International Conference in San Diego are available to comment on scientific advances being presented throughout the conference.
The American College of Surgeons (ACS) Clinical Congress 2024 will take place Saturday, October 19, through Tuesday, October 22, in San Francisco and will feature opportunities for members of the media to learn about the latest evidence-based practices and research in surgery and healthcare.
Total knee replacements performed with the help of a surgical robot have better outcomes on average than similar surgeries performed manually but can cost significantly more, a new study by UT Southwestern Medical Center researchers shows. T
Ann & Robert H. Lurie Children’s Hospital of Chicago is pleased to announce the first pediatric use of the novel fluorescent agent CYTALUX during surgery to remove lung metastases. The drug allows surgeons to better visualize cancer in the lung, as well as potentially detect additional cancerous nodules missed by preoperative imaging.
Clever bio-inks that sit inside the human body and restore damaged neurons could cure a whole swathe of diseases in the next 20 years: conditions that have baffled scientists and clinicians for centuries.
Corewell Health™ in Southeast Michigan is using virtual and augmented reality technology to enable patients to “tour” their own brains and assist physicians with planning and surgery.
NASSAU, Bahamas, April 26, 2024 /PRNewswire/ -- Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its cutting-edge JuxtaFlow® Renal Assist Device (RAD). This landmark recognition, fueled by the encouraging outcomes of the BIPASS-AKI feasibility study, coincides with the unveiling of pioneering research at the Society of Cardiovascular Anesthesiologists (SCA) Annual Meeting. It marks a significant leap forward in safeguarding kidney function for patients undergoing cardiac surgeries, addressing a key challenge in cardiothoracic surgery and critical care.
The expanding use of transcatheter technologies has changed the landscape in the treatment of valvular disease in adult cardiac patients, with valve surgery rapidly shifting to more complex interventions frequently involving other concomitant procedures.
Frailty is a well-established predictor of complications and death after surgery. However, patients over 65 who undergo a high-risk operation in the emergency room are at significantly increased risk of postoperative complications and death in comparison to the same patients who are assessed solely on their level of frailty, according to a study published in the Journal of the American College of Surgeons (JACS).
Surgeons from the Smidt Heart Institute at Cedars-Sinai will be attending the American Association for Thoracic Surgery (AATS) Annual Meeting April 27-30 in Toronto and are available to discuss the latest cardiac surgery news and research.
A thin film that combines an electrode grid and LEDs can both track and produce a visual representation of the brain’s activity in real-time during surgery–a huge improvement over the current state of the art.
At Hospital for Special Surgery (HSS), a 3D printer is manufacturing custom-made joint replacements for the most complex cases when a standard implant won’t work. HSS was the first hospital in the U.S. to house a 3D printing facility onsite for custom implants, in collaboration with LimaCorporate (recently acquired by Enovis).